Bath & Body Works, Inc. $BBWI Shares Bought by AQR Capital Management LLC

Key Points

• AQR Capital Management LLC substantially increased its stake in Bath & Body Works, acquiring an additional 2.9 million shares and raising its total ownership by 267.8% to nearly 4 million shares.
• Bath & Body Works reported a quarterly EPS of $0.37, meeting analysts' expectations, but experienced a 0.8% revenue decline compared to the previous year.
• The company declared a $0.20 quarterly dividend, translating to an annual yield of 2.5%, with a payout ratio of 23.74%.

AQR Capital Management LLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 267.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,993,173 shares of the company's stock after buying an additional 2,907,506 shares during the quarter. AQR Capital Management LLC owned about 1.87% of Bath & Body Works worth $121,073,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in BBWI. SVB Wealth LLC purchased a new position in shares of Bath & Body Works in the 1st quarter worth $35,000. Golden State Wealth Management LLC increased its holdings in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares in the last quarter. UMB Bank n.a. increased its holdings in Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares in the last quarter. Ancora Advisors LLC acquired a new stake in Bath & Body Works in the 4th quarter valued at $67,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Bath & Body Works in the 1st quarter valued at $69,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. UBS Group lowered their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, August 29th. JPMorgan Chase & Co. increased their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. The Goldman Sachs Group lowered their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a report on Friday, May 30th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Finally, Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday, August 28th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Bath & Body Works has an average rating of "Moderate Buy" and an average target price of $41.62.

Bath & Body Works Stock Down 0.8%

Shares of Bath & Body Works stock traded down $0.24 during trading hours on Tuesday, hitting $28.24. 5,893,721 shares of the company's stock traded hands, compared to its average volume of 5,305,078. The stock has a 50 day simple moving average of $30.70 and a 200-day simple moving average of $30.38. The company has a market cap of $5.82 billion, a PE ratio of 8.38, a PEG ratio of 1.01 and a beta of 1.49. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company's revenue for the quarter was down .8% compared to the same quarter last year. During the same period last year, the firm earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.